AstraZeneca
Filings signal: Despite Covid losses, pharma earnings are promising
Each week, Pharmaceutical Technology’s journalists pick out insights from company filings that highlight sentiments in our sector. These filings signals…
AstraZeneca vaccine and blood clots: the risks explained
In mid-March, a number of European countries paused their rollout of the AstraZeneca (AZ) Covid-19 vaccine after reports of blood…
AstraZeneca and Merck obtain EMA orphan status for selumetinib
AstraZeneca and Merck (MSD) have secured the European Medicines Agency orphan designation for a MEK 1/2 inhibitor called selumetinib to…
AstraZeneca faces US DOJ probe for alleged funding of Iraqi terrorists
The US Department of Justice (DOJ) has reportedly launched an investigation into a lawsuit that alleges AstraZeneca bribed terrorists in…
AstraZeneca divests Atacand’s European rights for $210m
AstraZeneca has signed an agreement to sell the European commercial rights for its Atacand (candesartan cilexetil) drug to German pharmaceutical…
